Biopharma’s most comprehensive analysis; 15 years; FREE Summary

15th Annual Global Biopharmaceutical Manufacturing Study Global Industry Invitation   Dear Colleague,   Participate in the industry's most comprehensive analysis of biomanufacturing!   Your participation is important as we benchmark 15 years of critical global and regional trends affecting the biopharmaceutical industry. Last year over 600+ biomanufacturers and suppliers participated globally. This year, our 15th, we expect even more!   All participants receive: • A FREE Aggregated Summary of this year’s results • Our Top 15 BioManufacturing Trends Analysis! • Opportunity to contribute your voice to global biomanufacturing benchmarking.     • Responses are aggregated and confidential. • We will contribute $15 (up to $2,000) to a charity of your choice or a $15 Amazon certificate. • Takes between 15-25 minutes, depending on your areas of expertise.     This year, we celebrate 15 years of benchmarking the dramatic advances in bioprocessing, new technologies, and emerging trends. Your participation, as an industry expert makes it possible to cover new industry areas that reflect critical changes and trends; new technologies, budgets, single-use, downstream bioprocessing, fill/finish, hiring, vendors, and many other critical areas. Thank you for your participation.     Survey Methodology: The Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production by BioPlan Associates, Inc. yields a composite view and trend analysis from 250 responsible individuals at biopharmaceutical manufacturers and contract manufacturing organizations (CMOs) in 28 countries. The methodology also includes an additional 190 direct suppliers of materials, services and equipment to the biopharma industry. This survey covers such issues as: new product needs, facility budget changes, current capacity, future capacity constraints, expansions, use of disposables, trends and budgets in disposables, trends in downstream purification, quality management, hiring issues, and employment. The quantitative trend analysis provides details and comparisons of production by biotherapeutic developers and CMOs. It also evaluates trends over time, and assesses differences in the world's major markets in the U.S. and Europe.